Sensitivity analyses showed that most results of the associations between TyG and all-cause/cause-specific mortality were robust in T2DM patients without CHF, without CAD, without stroke, without CKD, or without insulin treatment at baseline (Supplemental Tables 6–9). The gene discussed is INS; the disease is congestive heart failure.